These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 18509804)

  • 41. Seasonal and pandemic influenza preparedness: science and countermeasures.
    Fauci AS
    J Infect Dis; 2006 Nov; 194 Suppl 2():S73-6. PubMed ID: 17163392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of influenza neuraminidase inhibitors.
    Abdel-Magid AF; Maryanoff CA; Mehrman SJ
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):776-91. PubMed ID: 11899618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [No evidence of fewer influenza complications with oseltamivir].
    Bonneux L
    Ned Tijdschr Geneeskd; 2009; 153():A1127. PubMed ID: 19857319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuraminidase inhibitors were widely used in the UK during the 2009 influenza A(H1N1) pandemic.
    Nguyen-Van-Tam JS; Nicholson KG
    J Clin Virol; 2011 Feb; 50(2):183. PubMed ID: 21112812
    [No Abstract]   [Full Text] [Related]  

  • 45. Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir.
    Salvatore M; Laplante JM; Soave R; Orfali N; Plate M; van Besien K; St George K
    Transpl Infect Dis; 2020 Aug; 22(4):e13336. PubMed ID: 32449254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review: Neuraminidase inhibitors reduce symptomatic influenza; oseltamivir does not reduce hospitalizations.
    Millard PS
    Ann Intern Med; 2014 Oct; 161(8):JC2. PubMed ID: 25329219
    [No Abstract]   [Full Text] [Related]  

  • 47. ECDC public consultation on the use of neuraminidase inhibitors.
    Eurosurveillance editorial team
    Euro Surveill; 2016; 21(7):pii=30140. PubMed ID: 27358927
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparison of the clinical effectiveness of three neuraminidase inhibitors for Japanese pediatric patients with influenza in the 2013/2014 season].
    Hishiki H; Ishiwada N; Naito S; Nagasawa K; Someya T; Inoue N; Haraki M; Kurosaki T; Kameoka Y; Suzuki K
    Jpn J Antibiot; 2015 Dec; 68(6):337-43. PubMed ID: 27004397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Should neuraminidase inhibitors be prescribed for patients with influenza?
    Patel DM; Pitts SR; Hargraves J
    Ann Emerg Med; 2014 Jan; 63(1):54-5. PubMed ID: 23932720
    [No Abstract]   [Full Text] [Related]  

  • 50. [Influenza becomes treatable. Breakthrough against the last great epidemic?].
    Einecke D
    MMW Fortschr Med; 1999 Dec; 141(49-50):4-6. PubMed ID: 10726138
    [No Abstract]   [Full Text] [Related]  

  • 51. [Tamiflu resistance].
    Nau JY
    Rev Med Suisse; 2006 Dec; 2(91):2886. PubMed ID: 17236332
    [No Abstract]   [Full Text] [Related]  

  • 52. [Procedure in V.a. influenza].
    Vogel VG
    MMW Fortschr Med; 2006 Jan; 148(4):60-1. PubMed ID: 16502803
    [No Abstract]   [Full Text] [Related]  

  • 53. New options for the prevention of influenza.
    Cox NJ; Hughes JM
    N Engl J Med; 1999 Oct; 341(18):1387-8. PubMed ID: 10536132
    [No Abstract]   [Full Text] [Related]  

  • 54. The course of fever following influenza virus infection in children treated with oseltamivir.
    Suzuki E; Ichihara K
    J Med Virol; 2008 Jun; 80(6):1065-71. PubMed ID: 18428131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Resistance in influenza viruses].
    Hungnes O; Dudman SG
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2601-6. PubMed ID: 19023375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
    Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
    Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2011 Jan; 53(1355):1-3. PubMed ID: 21212742
    [No Abstract]   [Full Text] [Related]  

  • 58. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
    Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
    Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuraminidase inhibitors for influenza: a call for better research.
    Lancet; 2015 Oct; 386(10003):1510. PubMed ID: 26530602
    [No Abstract]   [Full Text] [Related]  

  • 60. Neuraminidase inhibitors for treatment of influenza.
    Ebell MH
    Am Fam Physician; 2004 Jun; 69(12):2824. PubMed ID: 15222647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.